Is neglect of self-clearance biasing TB vaccine impact estimates?Friday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South AfricaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
WHO evidence considerations for vaccine policy development for tuberculosis vaccines intended for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO preferred product characteristics for new tuberculosis vaccineFriday, August 9, 2024Availability, Policy and frameworksRead More
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccinesFriday, August 9, 2024AvailabilityRead More
New tuberculosis vaccines: advances in clinical development and modellingFriday, August 9, 2024Availability, Epidemiological impactRead More
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesFriday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
